ArticleCancers2022

Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial.

Arif Manji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.